Agoracom Blog

CLIENT FEATURE: Garibaldi (GGI: TSX-V) Surface sampling recently returned high-grade silver up to 8,000 g/t Ag + high-grade gold up to 52.6 g/t Au

Posted by AGORACOM-JC at 11:02 AM on Tuesday, September 23rd, 2014


  • $1.7 million in working capital as per latest financials (Apr 30)
  • Attractive share structure
  • no warrants, no major financings since 2009
  • Drilling in progress – strong news flow from Mexico and B.C.


  • Synergistic mix of business, market & geological expertise
  • Drilling underway at La Patilla Gold Property (high-grade targets) plus multiple drill-ready targets at 3 district-scale projects in Mexico
  • Largest landholder (262km2) among juniors in Sheslay Cu – Au porphyry discovery area at top of B.C’s Golden Triangle



Through the strength of its geological team and the use of cutting- edge technology and proprietary data, Garibaldi has built a foundation for lasting success in Mexico:

  • GGI continues to accurately pinpoint the most prospective targets for potential new discoveries in large, district-scale land packages
  • Project value is being cost-effectively unlocked
  • Financial strength is being built (i.e., sale of Temoris option, current Tonichi pilot coal program generating royalty income)

La Patilla Project

  • First-ever diamond drilling at the La Patilla gold property in Sinaloa state has returned highly encouraging gold values near-surface, including an interval grading 10.4 grams per tonne gold over 8.5
  • Five of six holes drilled to test the La Patilla vein system intersected broad zones of mineralization along 75 metres of strike length to depths of approximately 50 metres

Rodadero North Project

  • Drilling along almost 100 meters of strike length has returned significant high-grade silver intersections within 50 meters of surface, and mineralization remains open in all directions;
  • SE-14-03 intersected 1,935 g/t Ag (62.2 oz/t) between 4 and 5 meters’ depth while the most recent hole (SE-14-06) – the farthest step-out from previously reported discovery hole SE-14-01 – has produced the widest mineralized intercept to date;
  • Surface sampling at three target areas immediately southeast and east of Silver Eagle has returned high-grade silver (up to 8,000 g/t Ag) in addition to high-grade gold (up to 52.6 g/t Au) as explained further in this update;
  • As Garibaldi commences a second round of drilling at Silver Eagle, the total number of mineralized target areas within the 45 sq. km Rodadero North Project has increased from eight to 11.
  • Phase 2 diamond drilling continues, surface sampling results from mineralized outcrops indicate continued high silver values in addition to a significant increase in base metal content (up to 14.9% lead and 1.8% zinc) 1.5 km to 3 km south of discovery hole SE-14-01.


  • Successful exploration methods developed in Mexico are now being adopted to rapidly advance the company’s 100%-owned Grizzly Property
  • Multiple targets are being identified over 15 km from Grizzly West to Grizzly Central
  • GGI is the largest landholder among juniors in this highly prospective, under-exploited new Cu-Au porphyry discovery area in prolific Stikine Arch
  • Recently announced that it has acquired two highly prospective Cu-Au porphyry properties within the Stikine Arch

Red Lion

  • The Red Lion prospect, comprising 35 sq. km, is located 60 km south of AuRico Gold’s Kemess mine and adjoins the Kiska Metals’ Kliyul Cu-Au porphyry project under option to Teck Resources Ltd. The Red Lion shows extremely strong Cu-Au stream sediment geochemistry in both Government Regional Geochemical Survey responses and follow-up proprietary surveys. Access and infrastructure at Red Lion are excellent with the powerline to the Kemess South mine only three km away.

Mount Sister Mary (MSM)

  • The MSM prospect, comprising 58 sq. km, is located approximately 50 km northeast of Imperial Metals’ Red Chris mine and is underlain by similar Triassic and Jurassic volcanic and plutonic rocks. Government Regional Geochemical Survey responses confirm prior assessment work in which at least eight Cu-Ag-Au showings have been documented on the property.

12 Month Stock Chart


Supreme Appoints Chris Bechtel to Advisory Board

Posted by AGORACOM-JC at 8:35 AM on Tuesday, September 23rd, 2014

VANCOUVER, BRITISH COLUMBIA–(Sept. 23, 2014) - Supreme Pharmaceuticals Inc. (the “Company”) (OTCBB:SPRWF) (CSE:SL) is pleased to announce the appointment of Chris Bechtel to its advisory board. Mr. Bechtel brings a wealth of experience in capital markets, start-ups, and medicinal marijuana to the Company.

Mr. Bechtel launched a small business in the oil and gas industry in Houston, Texas in 1983 at the age of 23, which he then grew to revenues of over $30 million in six countries. In 2006, Mr. Bechtel sold his business to Weatherford International, one of the largest global providers of oil and gas services. Mr. Bechtel continues to run the original labs business, as well as other divisions for Weatherford, representing a combined staff of 2,500 employees and gross revenues of approximately $500M.

Mr. Bechtel became deeply involved in the marijuana industry after investigating the medical benefits of cannabis for an immediate family member. This led Mr. Bechtel to become a private investor in, and consultant and advisor to, over half-a-dozen companies in the cannabis sector.

“We are thrilled by this addition to our team,” said David Stadnyk, President and CEO of Supreme Pharmaceuticals. “Chris has a deep understanding of the cannabis industry, knows how to grow and run a large multinational business, and brings great strategic value to the Company.”

Mr. Bechtel stated, “Growing a fledgling startup into a successful international business was one of the most gratifying experiences of my career; Supreme is well on its way to taking the same journey, and I am excited to be able to support that process in an industry that can bring so many benefits to so many people.”

Supreme Pharmaceuticals Inc.
Investor Relations
(604) 674-2191

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway:

KWG Makes International Patent Claim; Steel and Chrome Giants Interested in Offtake and Marketing Alliance, Engineering and Construction

Posted by AGORACOM-JC at 10:42 AM on Monday, September 22nd, 2014

TORONTO, ONTARIO–(Sept. 22, 2014) - KWG Resources Inc. (TSX VENTURE:KWG)(FRANKFURT:KW6) has filed an international patent application under the Patent Cooperation Treaty. This will provide KWG with the right to file patent applications in over 140 countries around the world in order to secure its rights to its new method of refining chromite ore into ferrochrome by means of natural gas. The disclosed subject matter of this PCT application is supported by results of ongoing metallurgical tests being conducted on behalf of KWG by XPS Consulting and Testwork Services.

KWG has received expressions of interest in creating two strategic alliances:

  • A global steel company has proposed to provide project engineering and construction expertise and to market intermediate products for primary stainless steel casting. In this regard, KWG is studying the opportunity to build a facility to produce custom-made stainless steel billets for global export to stainless steel makers for remelting and dilution with iron.
  • A large ferrochrome producer has proposed a strategic marketing alliance for the global charge chrome market.

The parties are mutually exploring terms for offtake agreements for such products that could support future project financing facilities. These plans are being developed based on the commercial potential of the new method of refining chromite ore into ferrochrome by means of natural gas disclosed in the patent application. The customized cast billets contemplated for production at the proposed casting plant could become an export vehicle for the combined content of Canadian chromium, nickel and iron and the hydro-electricity and natural gas consumed to produce them.

About KWG: KWG has a 30% interest in the Big Daddy chromite deposit and the right to earn 80% of the Black Horse chromite where resources are being defined. KWG has also acquired patent interests, including a method for the direct reduction of chromite to metalized iron and chrome using natural gas. KWG also owns 100% of Canada Chrome Corporation which has staked claims and conducted a $15 million surveying and soil testing program for the engineering and construction of a railroad to the Ring of Fire from Exton, Ontario.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding ForwardLooking Statements: This Press Release contains or refers to “forward-looking information” within the meaning of applicable Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, “occur” or “be achieved”. All information, other than information regarding historical fact that addresses activities, events or developments that KWG believes, expects or anticipates will or may occur in the future is forward-looking information. Forward-looking information contained in this Press Release is subject to a number of risks and uncertainties that may cause the actual results of KWG to differ materially from those discussed in the forward-looking information, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, KWG. Risks and uncertainties may include: the general risks associated with the mining industry, adverse changes in commodity prices, currency and interest rate fluctuations, increased competition and general economic and market factors, risks associated with exporting custom steel billets, the risk that the new method of refining chromite ore into ferrochrome by means of natural gas that is the subject of the PCT application does not prove efficient or economical, the scope, likelihood of grant, enforceability, infringement, freedom to operate, or commercial value relating to the patent applications to be used to support the commercialization of the new method of refining chromite ore into ferrochrome by means of natural gas is worse than expected, the grant or approval of a patent on any invention disclosed in the patent applications relating to the commercialization of the new method of refining chromite ore into ferrochrome by means of natural gas is limited or does not materialize, completion of the off-take agreements does not materialize, completion of the strategic alliances does not materialize, the results of any feasibility studies, design, engineering or construction of the proposed project are worse than expected, or assumptions underlying the forward looking statements prove incorrect. We do not intend and do not assume any obligation to update these forwardlooking statements, except as required by law. Readers are cautioned not to put undue reliance on such forwardlooking statements.

Shares issued and outstanding: 777,842,468

KWG Resources Inc.
Bruce Hodgman

Supreme Completes First Tranche of Previously Announced Private Placement

Posted by AGORACOM-JC at 8:54 AM on Monday, September 22nd, 2014



Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (CSE:SL) is pleased to announce that it has closed the first tranche of its previously announced unit financing (see news releases dated August 15th and September 4, 2014) for total gross proceeds of $2,239,232.50 (the “Financing“). At closing, Supreme issued 8,956,930 Units (comprised of 8,956,930 common shares of the Company (“Common Shares“) and 4,478,465 Common Share purchase warrants (“Warrants“)) at a price of $0.25 per Unit. Each Warrant is exercisable for one Common Share at a price of $0.50 per share prior to September 22, 2015, subject to an accelerated expiry period upon 30-days notice by the Corporation to the subscriber, if the Common Shares trade at or above $0.70 for any five (5) day period during the term of the Warrants. Directors, senior officers and other insiders of the Corporation purchased an aggregate of 660,000 Units pursuant to the Financing. The Company paid finder’s fees of $65,320 and issued 287,280 Warrants to certain arm’s-length parties in the connection with the subscriptions of certain subscribers who participated in the private placement.

The Common Shares and Warrants issued pursuant to the private placement are subject to a hold period that expires January 23, 2015. Following closing, Supreme has 68,341,565 Common Shares issued and outstanding.

The Company intends to use the proceeds of the Financing for the development of the Company’s Kincardine facility and general working capital purposes. Based on the number of investors who have already submitted subscription agreements for the final tranche of the Financing, Supreme anticipates moving quickly towards a second closing prior to the end of September.


This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. More particularly and without limitation, this news release contains forward‐looking statements and information relating to the use of proceeds of the private placement, as well as the Company’s corporate strategy, participation in second tranche by those investors who have submitted subscription agreements to the Company but were not included in the first tranche, and having sufficient subscribers to close a second tranche. The forward‐looking statements and information are based on certain key expectations and assumptions made by management of the Corporation, including, without limitation, the Company’s ability to complete the remainder of the private placement. Although management of the Corporation believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward‐looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Corporation relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward‐looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and related regulations. Accordingly, readers should not place undue reliance on the forward‐looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward‐looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

Supreme Pharmaceuticals Inc.
Investor Relations
(604) 674-2191

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway:

INTERVIEW: Uragold Bay Resources Goes “Beyond The Press Release” to Discuss Recent Acquisition

Posted by AGORACOM-JC at 8:14 PM on Thursday, September 18th, 2014


Bernard Tourillon, Chairman, CEO and Director of Uragold Bay Resources goes “Beyond The Press Release” to discuss Letter Of Intent Regarding the Acquisition of 32 Claims Covering the Section of the 6.5 KM Long Historical Beauce Paleoplacer Gold Channel not Owned by Uragold.

Hub On AGORACOM / Corporate Profile / Watch Interview!

Newnote Financial Corp. to Start Trading on the OTCQB

Posted by AGORACOM-JC at 12:47 PM on Thursday, September 18th, 2014

Newnote Financial Corp. (the “Company”), (OTCQB: NWWTF CSE: NEU; FSE: 1W4) is pleased to announce that it has commenced trading on OTCQB®, the venture market for entrepreneurial and development stage companies. OTC Markets Group announced today that Newnote Financial has been verified for trading on OTCQB, effective September 18, 2014.

The OTCQB venture marketplace offers investors transparent trading in entrepreneurial and development stage U.S. and international companies. Beginning March 26, 2014, OTCQB companies will be required to meet new standards and eligibility requirements. To be eligible for OTCQB, companies must meet a minimum one-penny ($0.01) bid price test, be current in their reporting and undergo a new annual verification and management certification process designed to improve the information available to investors.

“We are very pleased to add Newnote Financial to our expanding universe of OTCQB companies,” commented Douglas Rogers, Managing Director of Merriman’s Capital Markets Advisory Group. “Advising our clients on best practices regarding their material information and financial reporting requirements is a key component of our advisory platform at Merriman. We look forward to supporting the Newnote Financial management team on the OTCQB market.”

Paul Dickson, President and CEO states: “This is an important milestone for the Company as it seeks to expand its presence in the United States of America. The Company is fully reporting in Canada and listed on the CSE Stock Exchange as well as the Frankfurt Stock Exchange. We are pleased to work with Merriman Capital Inc., whose hard work and diligence has allowed us to achieve our listing on the OTCQB.”

About Newnote

Newnote Financial Corp. is pioneering innovative crypto-currency and Bitcoin related software products and services geared at the growing business segment of this bourgeoning market. Newnote has positioned itself to be a leading contender in delivering opportunities to startup businesses world-wide and continues to create new opportunities for its clients and its shareholders. Newnote has a clear vision on the direction in which this new and unique business is headed and is continually adjusting and adopting new business practices in both technology and the policies & procedures required by banks and securities regulators.

About Merriman Capital, Inc.

Merriman Capital, Inc. is a full service investment bank and Broker-Dealer that facilitates efficient capital formation through a proprietary digital network, and offers Capital Markets Advisory and comprehensive Corporate Brokerage services for public and private companies. The firm also provides equity and options execution services for sophisticated investors and differentiated research for high growth companies. Merriman Capital, Inc. is a wholly owned brokerage subsidiary of Merriman Holdings, Inc. (OTCQX: MERR) and is a leading advisory firm for publicly traded, high-growth companies.

Digital Capital Network, powered by Merriman Capital, is a capital marketplace that enables highly targeted and more efficient execution of transactions. Please visit our website for more information on how you can be a part of our Digital Capital Network: Digital Capital Network, Inc. is a wholly owned subsidiary of Merriman Holdings, Inc. All operations on the Digital Capital Network are currently being executed by Merriman Capital, Inc.

Merriman Capital, Inc. is a registered broker-dealer and member of The Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC)

Company Contact Information

Paul Dickson
President, CEO & Director
Newnote Financial Corp.
Suite 709-700 West Pender Street
Vancouver, BC V6C 1G8
direct: 604-800-6749
fax: 604-685-3833

Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business and trading in the common stock of Newnote Financial Corp. The forward-looking information is based on certain key expectations and assumptions made by the company’s management. Although the company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the company can give no assurance that they will prove to be correct. These forward-looking statements are made as of the date of this press release and the company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The CSE has not reviewed, approved or disapproved the content of this press release.

National Medical Marihuana Awareness and Outreach Strategy

Posted by AGORACOM-JC at 8:09 AM on Thursday, September 18th, 2014


VANCOUVER, BC / September 18, 2014 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) is pleased to announce along with it’s Joint Venture partner Lexaria Corp that Maureen McGrath Host of the popular CKNW Sunday Night Sex Show and a registered nurse will be leading a National Medical Marihuana Awareness and Outreach Strategy.

Maureen specializes in reproductive and sexual health for men and women. She is in private practice both in North Vancouver and at Cross Roads Clinic in Vancouver where she see patients with sexual health issues.

Maureen’s background includes business development, advocacy and clinical research in the field of spinal cord injury as well as the biotechnical industry. A regular health contributor to radio and television, she is also a guest columnist for the 24Hours Newspaper.

Maureen is a sought after lecturer and routinely educates physicians, nurses, allied health, industry and the public on reproductive and sexual health and other quality of life issues. She is an invited guest lecturer an at the University of British Columbia and Simon Fraser University where she shares her knowledge base with undergraduate and medical students on bladder, bowel & sexual health.

Maureen is the Chair of the BC Chapter of Canadian Nurse Continence Advisors. Maureen is on the Board of the College of Midwives of British Columbia and on the Advisory Board for the Be More Than A Bystander Program with EVA BC and the BC Lions. She is a long time Mentor with Minerva’s “Women Helping Women Work” Program. Maureen is passionate about raising awareness about violence against women in homes, on the street and in the workplace.

As part of the national outreach plan, Maureen will be educating physicians, pharmacists, health care practitioners, and the public on the benefits and responsible use of medical marijuana for patients in need. Enertopia intends for Maureen to reach out via town hall – style meetings as well as through the media, and to build a network of people interested in the medical marihuana field for advocacy of the safe and therapeutic use of medical marihuana.

Further details of the National educational awareness campaign will be forth coming over the coming weeks.

“I am excited at the opportunity to help educate the health community on the potential benefits of Medical Marihuana and its many uses,” stated Maureen McGrath

Enertopia is very happy to welcome Maureen to our advocacy group for education and learning for physicians and patients in search of natural healing options.” Stated President / CEO Robert McAllister.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit or call

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that Maureen McGrath will have any meaningful impact on doctor and patient awareness and or that the Company will be able to obtain future financings.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway:

I Would Rather Having Nothing But A Dream, Then Everything And No Dream.

Posted by AGORACOM at 2:14 AM on Thursday, September 18th, 2014

If You Are Not Where You Want To Be, It Is Because You Are Not Making The Sacrifice.

I’d Rather Have Nothing But A Dream, Then Everything And No Dream. If You Don’t Understand What That Means, Open Your Eyes And Learn Before You Close Your Eyes And Learn The Hard Way.

INTERVIEW: AGORACOM Sector Spotlight – $2.4B Medical Marijuana Industry

Posted by AGORACOM-JC at 12:25 PM on Wednesday, September 17th, 2014

Welcome to Sector Spotlight a production of AGORACOM in which we talk to CEOs and executives of companies in which we believe to be notable sectors so that you can potentially profit from them.

Today we’ll be discussing Medical Marijuana. Joining us is AGORACOM Chief Market Commentator Allan Barry Laboucan and Chris Bunka, CEO & President and Chairman of the board of Lexaria Corp.

Hub On AGORACOM / Corporate Profile / Watch Interview Now!

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway:

Supreme Provides Construction Update

Posted by AGORACOM-JC at 8:47 AM on Wednesday, September 17th, 2014

VANCOUVER, BRITISH COLUMBIA–(Sept. 17, 2014) - Supreme Pharmaceuticals Inc. (the “Company”) (OTCBB:SPRWF)(CSE:SL) is pleased to report that it has made significant progress regarding the construction and required security implementation at its 342,000 square foot greenhouse facility located in Kincardine, Ontario (the “Greenhouse”).

Backed by strong support from the local municipality and business community, the Company has been able to move quickly to implement its proposed plan to produce up to 24,000,000 grams of medical marijuana, for which the Company has received a conditional pre-approval letter from Health Canada dated January 22, 2014 (the “Letter“). The Letter sets forth the conditions pursuant to which the Company’s application to be a Licensed Producer under the Marihuana for Medical Purposes Regulations (“MMPR“) may be granted, including the implementation and final inspection by Health Canada of certain cultivation, quality assurance, security and storage strategies. The Company is already in receipt of the required security clearances for its key personnel, as required by Health Canada. Locally, the Company has received all necessary approvals from the municipality, local law enforcement and local fire authorities. Marcomm Security Systems Group Inc., 2013 Security Integrator of the Year, is currently working to complete the installation and commissioning of the electronic security systems to be utilized at the Greenhouse. A level 8 storage vault capable of housing the Company’s production has been installed and the remaining physical security measures are near completion.

Peter Herburger, President and CEO of the Kincardine subsidiary stated, “We are thankful for the strong support from the local community, from the municipality, to the tradespeople to the local residents. With the support of Kincardine we have been able to maintain a construction schedule which will allow us to be ready to grow medical marijuana before the end of this year.”

The Company anticipates being ready for the pre-licenses inspection by Health Canada to verify the Company’s compliance with the requirements of the MMPR in November 2014 and looks forward to continuing its positive relationship with the regulator.

David Stadnyk, President and CEO of the Company stated, “Due to its size, local support the operational plan developed by management, the Greenhouse presents the opportunity to produce a large volume of high-quality, low-cost medical marijuana by applying commercial agriculture technology combined with the natural advantages of a greenhouse.”


This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the expected volumes from production; timing for completion of the Greenhouse; timing for implementation of required security measures; the timing for review of the Greenhouse by Health Canada, the subsequent issuance of a MMPR License and the conditions attached thereto; the construction schedule for the Greenhouse, and the expected start of commercial production. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on and such factors as the Company failing to acquire final MMPR license; delays in construction; additional competition in the marketplace; changes to the regulatory landscape; future jurisprudence regarding the MMPR process and implementation; the inability to source the technology and expertise needed to meet the conditions of the MMPR; the Company’s failure to attract and retain qualified horticultural personnel, unexpected conditions or diseases affecting production and general market conditions. This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995.

Supreme Pharmaceuticals Inc.
Investor Relations
(604) 674-2191

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: